Sunday, July 13, 2014
Inquirer Daily News

Daniel Hoffman

Pharma facts 2012: Health care premiums will go up, way, way up

Tuesday, January 1, 2013, 10:00 AM
Editor’s Note: As the year draws to a close, over the next four days, Check Up will be sharing one new Pharma fact a day that was an important breakthrough in the world of pharmaceuticals in 2012. Today, Check Up delves into health care premiums. This month the CEO at Aetna, one of the US's... Read more

Tis' the season for pharma's tricks

Friday, December 21, 2012, 12:40 PM
The Christmas season is one of enchantment, myth, childhood wishes and the noble spirit of peace on earth and good will toward all men. It remains for pharma to bring us back to hard reality. During a year-end flourish, several companies have acknowledged their illegal kickbacks to physicians, off-label... Read more

Pharma's "Vision" for the Future or Three Blind Mice?

Tuesday, December 4, 2012, 2:26 PM
By Daniel R. Hoffman, Ph.D. Last month the pharma columnist at Forbes, Matthew Herper, wrote that after "talking to executives around the drug industry," most are pursuing one of the following three alternative scenarios: The blockbuster model, the expanded orphan strategy and the access model. Here... Read more

Let the Market Decide? Not if Pharma Can Help It

Monday, November 26, 2012, 12:09 PM
By Daniel R. Hoffman, Ph.D. The Right's reflexes on matters of drug therapy are consistent with the way they feel about everything else. Trumping even considerations of whether or not the bible offers specific guidance, the Right claims that an unregulated market represents the best way, in fact... Read more

Reponses to a Reader Who Wants to Get Serious

Wednesday, November 7, 2012, 4:58 PM
By Daniel R. Hoffman, Ph.D. Last week a reader, "Hjeff," replied to my posting in a rather exasperated tone, claiming he wanted a serious discussion about the big issues of health care. Since writers for publication are typically flattered when their musings inspire readers to serious thinking, I... Read more

Electing a President Means Choosing Your Health Care

Thursday, November 1, 2012, 11:40 AM
By Daniel R. Hoffman, Ph.D. This week The New Yorker's financial writer, James Surowiecki, persuasively made the case (see here) that the single, most important basis for casting next Tuesday's presidential vote involves medications and health care in general. "Health care," according to Surowiecki... Read more

Pharma is all in for Romney

Tuesday, October 23, 2012, 11:45 AM
by Daniel R. Hoffman, Ph.D. As a group, pharma employees probably array across the political spectrum in a fashion similar to their counterparts in other large, well-established, technical industries. Until the last couple of years, many of them on the business side identified strongly with their... Read more

A Thumbnail of Pharma's Challenges

Friday, October 12, 2012, 9:59 AM
by Daniel R. Hoffman, Ph.D. Last week one of pharma's newsletters briefly reviewed (see here) what they consider the five most important factors affecting the industry's relations with payers. Pharma clearly faces daunting challenges aside from those related to payers. The most formidable problems... Read more

To buy Forest Labs or not

Monday, October 1, 2012, 3:18 PM
by Daniel R. Hoffman, Ph.D. The Financial Times reported last week (see here) that a growing chorus of equity analysts has been strongly urging AstraZeneca's (AZ's) new CEO, Pascal Soriot, to buy Forest Labs. AZ is scheduled to lose U.S. patent protection on drugs that will account for one-third... Read more

As Obamacare dawns, Big Pharma rides into the sunset

Thursday, September 20, 2012, 7:43 AM
by Daniel R. Hoffman, Ph.D. Pennsylvania Bio is a trade group of biotechnology, medical device, diagnostic, pharmaceutical companies and suppliers in this part of the state. The organization's president, Chris Molineaux, has been diligently holding public forums on the important topics affecting health... Read more
About this blog

Check Up covers major health events in our region and offers everything from personal health advice to an expert look at health reform. Read about some of our bloggers here.

For Portions of this blog may also be found in the Inquirer's Sunday Health Section

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Also on
Stay Connected